| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/AJCN/74.3.328 |
| P698 | PubMed publication ID | 11522556 |
| P50 | author | Laurent Magy | Q30504249 |
| P2093 | author name string | Desport JC | |
| Vallat JM | |||
| Beaufrère B | |||
| Boirie Y | |||
| Preux PM | |||
| Couratier P | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 328-334 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | American Journal of Clinical Nutrition | Q7713500 |
| P1476 | title | Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis | |
| P478 | volume | 74 |
| Q37305916 | A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T mutant C57BL6/J mice. |
| Q35822554 | A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis |
| Q37594297 | A plural role for lipids in motor neuron diseases: energy, signaling and structure |
| Q64276226 | ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia |
| Q38552413 | AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis |
| Q33354106 | Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice |
| Q34797530 | Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis |
| Q39014987 | Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis. |
| Q92856754 | Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis |
| Q38575783 | Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach |
| Q59219368 | Amyotrophic lateral sclerosis |
| Q38160421 | Amyotrophic lateral sclerosis and skeletal muscle: an update. |
| Q33862624 | Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice |
| Q40084958 | Anthropometry of Arm: Nutritional Risk Indicator in Amyotrophic Lateral Sclerosis |
| Q64891664 | Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches. |
| Q35864714 | Association between diabetes and amyotrophic lateral sclerosis in Sweden |
| Q28546154 | Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis |
| Q45326900 | Body mass index and amyotrophic lateral sclerosis: a study of US military veterans |
| Q34187004 | Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis |
| Q39259780 | Brain metabolism in health, aging, and neurodegeneration |
| Q38312121 | Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease. |
| Q36341451 | Co-clustering phenome-genome for phenotype classification and disease gene discovery |
| Q40719786 | Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival |
| Q47253322 | Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. |
| Q36346085 | Diagnostic investigation and multidisciplinary management in motor neuron disease |
| Q49335981 | Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis |
| Q27026387 | Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review |
| Q39316849 | Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis |
| Q47136369 | Energy expenditure in frontotemporal dementia: a behavioural and imaging study. |
| Q34582888 | Energy intake and amyotrophic lateral sclerosis |
| Q37805077 | Energy metabolism in amyotrophic lateral sclerosis |
| Q37636674 | Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis |
| Q37285915 | Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model |
| Q90531525 | Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions |
| Q35086167 | Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions |
| Q92712389 | High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis |
| Q38105917 | High-fat and ketogenic diets in amyotrophic lateral sclerosis |
| Q88506724 | Hypermetabolism in ALS is associated with greater functional decline and shorter survival |
| Q51755449 | Hypermetabolism in ALS patients: an early and persistent phenomenon. |
| Q36786650 | Hypolipidemia in patients with amyotrophic lateral sclerosis: a possible gender difference? |
| Q49659203 | Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. |
| Q35987553 | Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis |
| Q36981069 | Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis |
| Q33899405 | Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis |
| Q47870164 | Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia |
| Q64076225 | Lipid Biomarkers for Amyotrophic Lateral Sclerosis |
| Q91867885 | Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review |
| Q39101800 | Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments |
| Q37165781 | Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons |
| Q35111080 | Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models. |
| Q62785679 | Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1G93A mouse model of amyotrophic lateral sclerosis |
| Q35089202 | Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis |
| Q37073851 | Nutrition and dietary supplements in motor neuron disease |
| Q40820451 | Nutrition with Gastrostomy Feeding Tubes for Amyotrophic Lateral Sclerosis in Canada |
| Q51825896 | Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism. |
| Q90341507 | Overview of Lipid Biomarkers in Amyotrophic Lateral Sclerosis (ALS) |
| Q51385320 | Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. |
| Q28748875 | Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis |
| Q36687156 | Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort |
| Q52805095 | Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies. |
| Q34128732 | Predictive equations over-estimate the resting energy expenditure in amyotrophic lateral sclerosis patients who are dependent on invasive ventilation support |
| Q36737158 | Premorbid body mass index and risk of amyotrophic lateral sclerosis |
| Q35036503 | Recent advances in amyotrophic lateral sclerosis research |
| Q37093737 | Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease |
| Q26827642 | Risk factors for amyotrophic lateral sclerosis |
| Q37674059 | SOD1-G93A mice exhibit muscle-fiber-type-specific decreases in glucose uptake in the absence of whole-body changes in metabolism |
| Q57804008 | Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status |
| Q22305776 | Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study |
| Q36805205 | Skeletal Muscle in Motor Neuron Diseases: Therapeutic Target and Delivery Route for Potential Treatments |
| Q47155349 | Specific Physical Exercise Improves Energetic Metabolism in the Skeletal Muscle of Amyotrophic-Lateral- Sclerosis Mice |
| Q40957672 | Statins accelerate disease progression and shorten survival in SOD1(G93A) mice |
| Q34537070 | Supportive and symptomatic management of amyotrophic lateral sclerosis |
| Q37272856 | Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis |
| Q92288329 | TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS |
| Q34979308 | TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis |
| Q90615812 | Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice |
| Q35557097 | The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease |
| Q38577066 | The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis. |
| Q36482355 | The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis |
| Q35576475 | The management of motor neurone disease. |
| Q89667122 | Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases |
| Q51653311 | Up‐regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis |
| Q52017620 | Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis |
| Q24644968 | Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis |
| Q34815254 | Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options |
| Q42730688 | What is "Hyper" in the ALS Hypermetabolism? |
| Q79805898 | [Review of nutritional and respiratory support in ALS] |
Search more.